{{Rsnum
|rsid=6773957
|Gene=ADIPOQ
|Chromosome=3
|position=186855916
|Orientation=plus
|GMAF=0.4885
|Gene_s=ADIPOQ,ADIPOQ-AS1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 15.0 | 45.1 | 39.8
| HCB | 36.5 | 46.0 | 17.5
| JPT | 34.5 | 46.0 | 19.5
| YRI | 42.9 | 39.5 | 17.7
| ASW | 29.8 | 40.4 | 29.8
| CHB | 36.5 | 46.0 | 17.5
| CHD | 37.6 | 52.3 | 10.1
| GIH | 9.9 | 45.5 | 44.6
| LWK | 52.7 | 36.4 | 10.9
| MEX | 20.7 | 55.2 | 24.1
| MKK | 37.8 | 50.6 | 11.5
| TSI | 14.7 | 52.9 | 32.4
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19165155
|Trait=Adiponectin Levels
|Title=Genome-wide Linkage and Association Anaylses to Identify Genes Influencing Adiponectin Levels: The GEMS Study
|RiskAllele=A
|Pval=5E-8
|OR=NR
|ORtxt=NR
|OA=1
}}

{{PharmGKB
|RSID=rs6773957
|Name_s=
|Gene_s=ADIPOQ
|Feature=
|Evidence=PubMed ID:19165155; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide Linkage and Association Anaylses to Identify Genes Influencing Adiponectin Levels: The GEMS Study. (Initial Sample Size: 997 cases, 989 controls; Replication Sample Size: NR); (Region: 3q27.3; Reported Gene(s): ADIPOQ; Risk Allele: rs6773957-A); (p-value= 0.00000005).This variant is associated with Adiponectin Levels.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA164740066
}}

{{PMID Auto
|PMID=19761474
|Title=Circulating high molecular weight adiponectin isoform is heritable and shares a common genetic background with insulin resistance in nondiabetic White Caucasians from Italy: evidence from a family-based study
|OA=1
}}

{{omim
|id=612556
|rsnum=6773957
}}

{{PMID Auto
|PMID=18776141
|Title=Common variants in the adiponectin gene (ADIPOQ) associated with plasma adiponectin levels, type 2 diabetes, and diabetes-related quantitative traits: the Framingham Offspring Study.
|OA=1
}}

{{PMID Auto
|PMID=21219602
|Title=Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs6773957
|overall_frequency_n=62
|overall_frequency_d=128
|overall_frequency=0.484375
|n_genomes=40
|n_genomes_annotated=0
|n_haplomes=52
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}